InsidersTradesSigma
Total declarations
Companies
▲ Purchases (25 ops.)
▼ Sales (17 ops.)
Explore the complete record of transactions filed by HLD Europe SCA, Director. Insider active across 2 companies, notably CLARIANE SE. Cumulatively, 45 filings have been logged. Total volume traded: €716.7m. The latest transaction was disclosed on 30 April 2026 — Acquisition. Regulator: AMF. The full history is accessible without signup.
Declarations45 total
€72,85818,400 shares@ €3.95970.0052% mcap0.1% of flow
ActionEuronext Paris
2026DD1113076·
Ideal exit: 25 Jan 2027 (T+270)
€114m1,765,673 shares@ €64.603.88% mcap13.3% of flow
ActionHors plateforme de négociation
2026DD1107318·
€31m484,327 shares@ €64.601.06% mcap3.6% of flow
ActionHors plateforme de négociation
2026DD1107319·
€68,68917,550 shares@ €3.91390.0049% mcap0.1% of flow
ActionEuronext Paris
2026DD1098783·
Ideal exit: 24 Nov 2026 (T+270)
€70,90318,221 shares@ €3.89130.0051% mcap0.1% of flow
ActionEuronext Paris
2026DD1091554·
Ideal exit: 20 Oct 2026 (T+270)
€192,55050,841 shares@ €3.78730.014% mcap0.3% of flow
ActionEuronext Paris
2026DD1090657·
Ideal exit: 24 Oct 2026 (T+270)
€192,55050,841 shares@ €3.78730.014% mcap0.3% of flow
ActionEuronext Paris
2026DD1091076·
Ideal exit: 16 Oct 2026 (T+270)
€231,35661,181 shares@ €3.78150.016% mcap0.4% of flow
ActionEuronext Paris
2026DD1089589·
Ideal exit: 10 Oct 2026 (T+270)
€94,85824,890 shares@ €3.81110.0068% mcap0.1% of flow
ActionEuronext Paris
2026DD1088726·
Ideal exit: 4 Oct 2026 (T+270)
€58m1,071,074 shares@ €54.002.34% mcap6.7% of flow
ActionHors plateforme de négociation
2026DD1088607·
€36,3519,253 shares@ €3.92860.0026% mcap0.1% of flow
ActionEuronext Paris
2026DD1087553·
Ideal exit: 27 Sept 2026 (T+270)
€28,1777,430 shares@ €3.79230.0020% mcap0.0% of flow
ActionEuronext Paris
2025DD1086629·
Ideal exit: 20 Sept 2026 (T+270)
€74,21019,636 shares@ €3.77930.0053% mcap0.1% of flow
ActionEuronext Paris
2025DD1086361·
Ideal exit: 18 Sept 2026 (T+270)
€46,45712,893 shares@ €3.60330.0033% mcap0.1% of flow
ActionEuronext Paris
2025DD1085730·
Ideal exit: 12 Sept 2026 (T+270)
€33,3218,737 shares@ €3.81380.0024% mcap0.1% of flow
ActionEuronext Paris
2025DD1074765·
Ideal exit: 6 Sept 2026 (T+270)
€83,93122,654 shares@ €3.70490.0060% mcap0.1% of flow
ActionEuronext Paris
2025DD1073837·
Ideal exit: 31 Aug 2026 (T+270)
€87m2,050,513 shares@ €42.5010.1% of flow
ActionEuronext Paris
2025DD1073449·
€63m1,471,596 shares@ €42.507.3% of flow
ActionEuronext Paris
2025DD1073451·
€150m3,522,109 shares@ €42.506.07% mcap17.4% of flow
ActionEuronext Paris
2025DD1073453·
Ideal exit: 30 Aug 2026 (T+270)
€61,21416,546 shares@ €3.69960.0044% mcap0.1% of flow
ActionEuronext Paris
2025DD1072789·
Ideal exit: 25 Aug 2026 (T+270)
€67,33719,601 shares@ €3.43540.0048% mcap0.1% of flow
ActionEuronext Paris
2025DD1071810·
Ideal exit: 21 Aug 2026 (T+270)
€47,47314,291 shares@ €3.32190.0034% mcap0.1% of flow
ActionEuronext Paris
2025DD1070851·
Ideal exit: 15 Aug 2026 (T+270)
€34m623,561 shares@ €54.001.36% mcap3.9% of flow
ActionHors plateforme de négociation
2025DD1063621·
€24m447,513 shares@ €54.000.98% mcap2.8% of flow
ActionHors plateforme de négociation
2025DD1063624·
€9m206,896 shares@ €43.500.36% mcap1.0% of flow
ActionHors plateforme de négociation
2025DD1041272·
25 of 45 declarations
About HLD Europe SCA
HLD Europe SCA is a long-term investment vehicle within the HLD group, known for supporting sizeable companies through periods of transformation, growth and consolidation. In the governance of Clariane SE, HLD Europe holds the position of reference shareholder and is represented on the Board of Directors, where it contributes to the group’s strategic and financial decision-making. Its entry into Clariane’s share capital was announced in 2024 as part of a capital increase designed to strengthen the company’s financial structure and support sustainable development. This transaction marked an important milestone, with HLD Europe bringing its long-term investor expertise to a business operating in an essential service sector linked to population ageing. In Exosens’ governance, HLD Europe is also a central stakeholder. The group has supported Exosens since its acquisition in 2021 and has become its principal shareholder. Exosens is a French specialist in high-end electro-optical technologies, operating in sensitive and strategic markets, notably defence and industrial applications. HLD Europe’s presence on the board reflects an engaged ownership model focused on value creation, capital discipline and international development. HLD Europe’s profile is that of an entrepreneurial institutional investor, experienced in structuring complex transactions, securing growth trajectories and supporting management teams over the long term. Its involvement in Clariane demonstrated an ability to address financing and governance issues in a demanding environment. At Exosens, its role reflects a strong conviction in innovation, industrial sovereignty and the scaling of high-potential technology platforms. In short, HLD Europe stands out for its recognised private equity expertise, active governance approach and strategic partnership mindset with leading listed and industrial companies.
